The treatment of colon cancer cells with the inhibitor of survivin—YM-155—reduced the pro-apoptotic activity of piperine [38], suggesting that its anticancer activity depends on survivin’s expression. The gene discussed is BIRC5; the disease is malignant colon neoplasm.